Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions
1 Assignment
0 Petitions
Accused Products
Abstract
There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I)
-
Citations
46 Claims
-
1-4. -4. (canceled)
-
5. A pharmaceutical formulation comprising
a pharmaceutical formulation which comprises: -
an aqueous suspension of particulate compound of formula (I) or a solvate thereof, and one or more preservatives, wherein the preservative comprises disodium edatate. - View Dependent Claims (9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)
-
-
6-8. -8. (canceled)
-
22. A pharmaceutical formulation which comprises:
-
an aqueous suspension of particulate compound of formula (I) or a solvate thereof wherein the particle size of the compound of formula (I) has been reduced. - View Dependent Claims (23, 24, 25, 26, 27, 28, 29, 30, 31, 37, 38, 39, 40, 41)
-
-
32. A container comprising a pharmaceutical formulation which comprises:
- an aqueous suspension of particulate compound of formula (I)
- View Dependent Claims (33)
- 34. A compound of formula (I)
-
36. A compound of formula (I)
-
42. (canceled)
- 43. A process for the preparation of a compound of formula (I) substantially in the form of equant or substantially equant particles which process comprises dissolving a compound of formula (I) in a suitable solvating solvent and crystallising the compound.
Specification